首页> 美国卫生研究院文献>Annals of Translational Medicine >Troubleshooting an isolate prolongation of activated partial thromboplastin time in a patient with acute myocardial infarction—a paradigmatic case report
【2h】

Troubleshooting an isolate prolongation of activated partial thromboplastin time in a patient with acute myocardial infarction—a paradigmatic case report

机译:解决急性心肌梗死患者激活的部分凝血活酶时间延长的孤立问题-病例报告

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We describe here the case of a 46-year-old man admitted to the emergency department (ED) and diagnosed with a non-ST elevation myocardial infarction. Before referring the patient to the coronary care unit and initiating antiplatelet and anticoagulant therapy, a highly prolonged activated partial thromboplastin time (APTT) was observed among results of laboratory testing. Results of mixing test showed complete correction of APTT, thus ruling out the presence of inhibitors of blood coagulation. On the following day, second line coagulation testing revealed normal activity of all clotting factors except factor XII, the concentration of which was found to be 1.5%. This result was suggestive for a diagnosis of inherited factor XII deficiency, thus highlighting the importance of combining clinical history, symptoms and results of first-line coagulation tests in similar emergency conditions.
机译:我们在这里描述的是一例46岁男子被送往急诊科(ED)并被诊断出患有非ST抬高型心肌梗塞的情况。在将患者转诊至冠状动脉护理部门并开始抗血小板和抗凝治疗之前,在实验室测试的结果中,观察到活化的部分凝血活酶时间(APTT)高度延长。混合测试的结果显示APTT的完全校正,因此排除了凝血抑制剂的存在。第二天,第二线凝血试验显示除凝血因子XII外所有凝血因子的活性均正常,发现凝血因子XII的浓度为1.5%。该结果提示了对遗传性XII缺乏症的诊断,从而突出了在类似紧急情况下结合临床病史,症状和一线凝血试验结果的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号